⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1841477 | 1.00 | — | — | |
| SCHEMBL1841480 | 1.00 | — | — | |
| SCHEMBL21022704 | 1.00 | — | — | |
| SCHEMBL447351 | 1.00 | — | — | |
| SCHEMBL2645499 | 1.00 | — | — | |
| SCHEMBL25752110 | 1.00 | — | — | |
| SCHEMBL2500151 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL31603692 | 0.98 | — | — | |
| Hydrochloric Acid SCHEMBL17574573 | 0.98 | — | — | |
| Hydrochloric Acid SCHEMBL15157492 | 0.98 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9233926-B2 | Compounds for stem cell differentiation | SANFORD-BURNHAM MEDICAL RESEARCH INSTITUTE (US) | 2016-01-12 | — | — | US | claimed |
| CN-104684893-A | Asymmetric auxiliary group | CHIRALGEN LTD | 2015-06-03 | — | — | CN | claimed |
| US-20250250287-A1 | HETEROCYCLIC COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS OF TREATMENT THEREWITH | BEIGENE SWITZERLAND GMBH (CH) | 2025-08-07 | — | — | US | disclosed |
| EP-4568973-A1 | HETEROCYCLIC COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS OF TREATMENT THEREWITH | BeiGene Switzerland GmbH (CH) | 2025-06-18 | — | — | EP | disclosed |
| CN-119654327-A | Heterocyclic compounds, compositions thereof and methods of treatment thereof | 百济神州(苏州)生物科技有限公司 | 2025-03-18 | — | — | CN | disclosed |
| US-20240116896-A1 | HETEROATOM SUBSTITUTED CYCLIC AND ALKYL AMINES AS ACTIVATORS OF SEROTONIN RECEPTORS | ATAI THERAPEUTICS, INC. (US) | 2024-04-11 | — | — | US | disclosed |
| WO-2024032703-A1 | HETEROCYCLIC COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS OF TREATMENT THEREWITH | BEIGENE, LTD. (KY) | 2024-02-15 | — | — | WO | disclosed |
| EP-3710439-B1 | KRAS G12C INHIBITORS | MIRATI THERAPEUTICS INC (US) | 2023-02-15 | — | — | EP | disclosed |
| EP-2872147-B1 | METHOD FOR MAKING CHIRAL OLIGONUCLEOTIDES | WAVE LIFE SCIENCES LTD (SG) | 2022-12-21 | — | — | EP | disclosed |
| EP-3710439-A1 | KRAS G12C INHIBITORS | Mirati Therapeutics, Inc. (US) | 2020-09-23 | — | — | EP | disclosed |
| EP-3458445-A1 | KRAS G12C INHIBITORS | Mirati Therapeutics, Inc. (US) | 2019-03-27 | — | — | EP | disclosed |
| EP-2034933-A1 | OPHTHALMOLOGICAL COMPOSITION AND USE THEREOF | ACRI.TEC AG Gesellschaft Für Ophtalmotologische Productie (DE) | 2009-03-18 | — | — | EP | disclosed |
| WO-2008034598-A1 | METHOD FOR THE SYNTHESIS OF HEXAHYDROFURO (2, 3-B) FURAN-3-OL COMPOUNDS | DSM IP ASSETS B.V. (NL) | 2008-03-27 | — | — | WO | disclosed |
| WO-2007147599-A1 | OPHTHALMOLOGICAL COMPOSITION AND USE THEREOF | ACRI.TEC AG GESELLSCHAFT FÜR OPHTALMOTOLOGISCHE PRODUCTE (DE) | 2007-12-27 | — | — | WO | disclosed |
| EP-1594835-A4 | METHOD OF PREPARATION OF HETEROCYCLIC MOLECULES WITH PHARMACEUTICAL PHARMACEUTICAL EXCIPIENT COSMECEUTICAL AGROCHEMICAL AND INDUSTRIAL USES | AUSPEX PHARMACEUTICALS INC (US) | 2007-05-02 | — | — | EP | disclosed |
| EP-1594835-A2 | METHOD OF PREPARATION OF HETEROCYCLIC MOLECULES WITH PHARMACEUTICAL PHARMACEUTICAL EXCIPIENT COSMECEUTICAL AGROCHEMICAL AND INDUSTRIAL USES | Auspex Pharmaceuticals, Inc. (US) | 2005-11-16 | — | — | EP | disclosed |
| US-6800636-B2 | FOR THERAPY OF CANCER | SCHERING CORPORATION | 2004-10-05 | — | — | US | disclosed |
| WO-2004064745-A2 | METHOD OF PREPARATION OF HETEROCYCLIC MOLECULES WITH PHARMACEUTICAL PHARMACEUTICAL EXCIPIENT COSMECEUTICAL AGROCHEMICAL AND INDUSTRIAL USES | AUSPEX PHARMACEUTICALS, INC. (US) | 2004-08-05 | — | — | WO | disclosed |
| US-20030040520-A1 | Farnesyl protein transferase inhibitors | GUZI TIMOTHY (US) | 2003-02-27 | — | — | US | disclosed |
| US-6362188-B1 | ANTICANCER AGENTS | SCHERING CORPORATION | 2002-03-26 | — | — | US | disclosed |